foxo4-dri human trial The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound Frontiers | Senolytic Peptide FOXO4-DRI
Description
Think of it like this: a doctor needs an X-ray to confirm a broken bone before putting on a cast
(2009) 89:1607S16S
People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness leading to death
doi: 10.1152/ajpendo.1978.235.6.E703
